Doris Engesser (Dr.Rer.Nat.) Email & Phone Number

Marlborough, MA, US

Future of Sales and SellingSales ProcessAccount /Key Account Management Role evolution Clinical Sales Targeted needs-based L&D Learning Systems and Technology Innovation, VR/AR

Marlborough, MA, US

Heading Sales CapabilitiesFuture of sales & selling across all divisions & regions in EMEA, commercial innovation, role evolution EMEA Strategic Plan: Lead People Strategy Development EMEA 2023-2026 Transforming Sales through people experiences

Marlborough, MA, US

Center of Excellence Change Leader roleLeading Strategy & execution for Sales Capabilities/Sales Enablement, Learning & Development at Boston Scientific EMEA, Multi-divisional: 6 Divisions + Growth Emerging Markets 1500+ peopleMember of Global Sales Enablement Council, Member of Global Learning Leadership Council Created and leading Field Engagement group.

Marlborough, MA, US

Sales Capabilities at Boston Scientific Europe (Multi-divisional - 6 Division, 1500+ Sales people)Center of Excellence with direct connect to the businesses Strategy, Roadmap and ExecutionDevising and leading strategic programmesStrategic and operational roleCommercial Capabilities strategic pillars: People, processes, systems and toolsFocus:-Change.

Wilmington, DE, US

• Member of the Global Innovation Senior Leadership team of USD 3.5 billion DuPont Nutrition & Health business working with a team of Global Innovation Directors under the Chief Science Officer and collaborating with the.
• N&H Strategy development and execution planning
• Innovation strategy, Innovation portfolio pipeline management, trained innovation champion
• Technology roadmapping, Open Innovation, Tech Scouting, Breakthrough Innovation, Global Project Management
• Functional Interface: DuPont Science and Technology, DuPont Corporate Business development, DuPont Corporate Sales & Marketing, DuPont Corporate Ventures, N&H strategy, N&H business division/commercial groups and other.

Wilmington, DE, US

• Responsible for the profitability (P&L owner) of DuPont Nutrition & Health's ( N&H 3.5 billion USD) global Diagnostics business reporting into Senior VP
• Managed global business ( 4 regions - NA, EMEA, ASPAC, LA) with and through regional business managers. Re-organised and led Global Marketing, Portfolio, PM teams and restructured Sales organisation (indirectly also.
• Implemented New DuPont Global Commercialization process and revamped Innovation/NPD Pipeline to address lacking product innovation (DuPont award received for successful and rapid commercialisation process.
• Built internal operations - production capability (move from contract manufacturing to inhouse production) achieving significant production cost efficiencies.
• Stabilized declining business, growing core business by 6%.
• Additional Special assignment/projects:- Global Integration & Synergies projects - commercial synergies projects following 7billion USD Danisco acquisition, delivering on PTOI synergies targets- Divisional Strategy and.

Wilmington, DE, US

• Business executive role for EMEA (Europe, Middle East, Africa) for the DuPont Food Safety business (P&L owner), reporting into President. Formed and led the European team - Sales, Marketing, Business Development.
• In addition took on and led Global Key Account Management and Sales Excellence for the global business to reach a global, harmonised account strategy and management processes, develop global commercial capabilities.

• Double role ( as stretch assignment) reporting into Global VP Specialty Business for Solae and for DuPont reporting into Exec Director / President DuPont Qualicon.
• First cross-SBU Sales & Marketing role established within the newly formed Nutrition & Health Platform within DuPont
• Achieved Double digit growth over consecutive years.Special assignments:Represented Nutrition & Health in DuPont Africa immersion programme (2010), spending several weeks in Africa with existing and potential.

• Responsible for 80 million USD business reporting into Regional VP Europe;Global Solae Business - US$1.3billion revenue, Solae was avDuPont-Bunge Joint Venture.
• Restructured sales organization for sales effectiveness and cost efficiencies.
• Customer segmentation & channel strategy implementation. Go-to-Market strategy developed and executed.
• Achieved growth over consecutive years 30% over 3 years despite flat, competitive market. Most profitable business segment in Europe. Successful pricing plan roll out with more than 10 Million USD bottom line impact..

Strategy Leader for Business Segment Europe, Middle East, CIS, South Africa Solae LLC, Solae was formed in 2003 through a Joint Venture between DuPont Protein Technologies and BungeEuropean Strategy Role; Business Development Developed and Emerging Markets, Channel Management – Direct/Distribution/Inside Sales, Product Portfolio/SKU Management incl Pricing.

Wilmington, DE, US

DuPont Protein Technologies and as of 2003 The Solae CompanyEuropean Strategy/Marketing Role, Due Diligence & Integration process leading to formation of The Solae Company ( merging 4 companies): Marketing & Sales Strategy, Cross-legacy and cross-functional Knowledge Transfer - R&D/Applications/Sales, Organizational & Competency Development, Sales and.

Certification, Business & Leadership

Professional Development

Leadership Programmes, Corporate Programmes, Alumni Programmes

Leadership Programme

Phd, Microbiological Sciences

Master Of Science - Ms